Goldman J N, O'Rourke K S, Goldman M B
Cell Immunol. 1985 Nov;96(1):26-37. doi: 10.1016/0008-8749(85)90337-5.
Previous work in our laboratory established that individual complement components can be regulated in vivo by administration of specific antibody or immunocompetent cells to newborns and in vitro by administration of specific antibody to cultured peritoneal macrophages or splenic fragments. Antibody-induced suppression of C4 was much longer lasting in cultured guinea pig splenic fragments than in cultured guinea pig peritoneal macrophages, suggesting that splenic fragments contained elements necessary for long-term suppression that were not present in the macrophage monolayers. This publication presents data in support of this concept. Antibody-treated splenic fragments from normal guinea pigs--but not from C4-deficient guinea pigs--elaborated a soluble factor (FsC4) that suppressed C4 production in previously untreated splenic fragments. FsC4 activity was most potent in splenic fragment culture supernatants at those times when intracellular and secreted C4 hemolytic activity and C4 antigen were at their lowest. C4 itself or a fragment of C4 was therefore unlikely to mediate suppression in this system. Residual anti-C4 antibody was ruled out as a mediator of FsC4 activity since it was shown by two independent methods that the amount of anti-C4 antibody carried over with the supernatant was orders of magnitude less than the amount necessary to cause suppression or to neutralize fluid phase C4 in fresh splenic fragment cultures. Preliminary data revealed that FsC4 activity may be mediated by two or more distinct molecular species or may be mediated by a single molecule that exhibits secondary size and charge heterogeneity. The identification of factors that are capable of regulating C4 suggests that, as with immunoglobulins, complement components may be regulated by complex networks of immunocompetent cells and their soluble products.
我们实验室先前的研究表明,通过给新生儿注射特异性抗体或免疫活性细胞,可在体内对单个补体成分进行调节;通过给培养的腹膜巨噬细胞或脾碎片注射特异性抗体,可在体外对单个补体成分进行调节。在培养的豚鼠脾碎片中,抗体诱导的C4抑制作用比在培养的豚鼠腹膜巨噬细胞中持续的时间长得多,这表明脾碎片中含有长期抑制所需的成分,而巨噬细胞单层中不存在这些成分。本出版物提供的数据支持了这一概念。来自正常豚鼠而非C4缺陷豚鼠的经抗体处理的脾碎片,可产生一种可溶性因子(FsC4),该因子能抑制先前未处理的脾碎片中的C4产生。在细胞内和分泌的C4溶血活性及C4抗原处于最低水平时,FsC4活性在脾碎片培养上清液中最为显著。因此,C4本身或C4的一个片段不太可能介导该系统中的抑制作用。残留的抗C4抗体被排除为FsC4活性的介导物,因为通过两种独立方法表明,上清液中携带的抗C4抗体量比在新鲜脾碎片培养物中引起抑制或中和液相C4所需的量低几个数量级。初步数据显示,FsC4活性可能由两种或更多不同的分子种类介导,也可能由一种表现出二级大小和电荷异质性的单一分子介导。能够调节C4的因子的鉴定表明,与免疫球蛋白一样,补体成分可能受免疫活性细胞及其可溶性产物的复杂网络调节。